Thomas Andrew Rowland serves as Executive at ANI PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Thomas Andrew Rowland has executed 1 insider transactions totaling $426.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 12, 2025 involved selling 4,975 shares valued at $426.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 12, 2025 | ANIP | $426.4K | Sale | 4,975 | $85.71 | Discretionary |
Thomas Andrew Rowland currently holds 40,794 shares of ANI PHARMACEUTICALS INC (ANIP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Andrew Rowland has been a net seller of ANIP stock. They have purchased $0 and sold $426.4K worth of shares.
Thomas Andrew Rowland's most recent insider trade was on Aug 12, 2025, when they sold 4,975 shares at $85.71 per share.
Get notified when new Form 4 filings are submitted